Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
asymptomatic, bilirubin, CEO, conference, Connecticut, elevation, feedback, harnessing, highest, inside, intervention, lifelong, Retiree, retirement, ribonucleic, role, RSU, timeline, timepoint, version
Removed:
aim, analytical, nausea, pain, RNA, tolerability, unlock, unmatched
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view